the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Lunenfeld-Tanenbaum Research Institute University of Toronto

Cardiovascular safety and reduction of CV risk with once weekly Semaglutide SUSTAIN-6 press release

New monoclocal GLP-1R antisera for use with human and murine cells & tissues now available

For updates to, Follow us on Twitter DanielJDrucker